首页> 外文期刊>Advances in Microbiology >Inhibitory Activities of Lactic Acid Bacteria against Multi-Drug Resistant Uropathogenic &i&Staphylococcus saprophyticus&/i& Isolated from Symptomatic Women in Lagos, Nigeria
【24h】

Inhibitory Activities of Lactic Acid Bacteria against Multi-Drug Resistant Uropathogenic &i&Staphylococcus saprophyticus&/i& Isolated from Symptomatic Women in Lagos, Nigeria

机译:乳酸菌对多药物抗性尿羟基酚蛋白抑制乳酸菌的抑制活性。葡萄球菌ββββ/ i&从症状妇女隔绝在拉各斯,尼日利亚

获取原文

摘要

The uropathogenic Staphylococcus saprophyticus is reported severally to be resistant to the drugs often used empirically for treatment of urinary tract infections (UTIs). Their ability to exhibit resistance to multiple drugs is a great de al of threat to successes recorded in the management of UTIs cause d by this pathogen. Lactic acid bacteria (LAB) have been demonstrated to exhibit an timicrobial activities but studies about their prospect against multi -drug resistant S. saprophyticus are quite few. This study therefore investigated acti vities of LAB against the multi-drug resistant S . saprophyticus recover ed fro m urine samples of symptomatic women. The three differ ent species of LAB ( Lactobacillus fermentum BTA 62, Lactobacillus johnsonii BTA 86 and Weis sella confusa BTA 40) previously isolated and identified by 16S rRNA s e quencing were selected based on their history of antimicrobial activities. Their m etabolites were employed in the antagonistic assays against six (6) mu lti-drug resista nt test pathogens recovered fro m urine samples of symptomatic, non-pregnant women attending clinics in Lagos, Nigeria and the control ( S . saprophyticus subs bovis strain DSM 18669) following standard procedures. The pathogens showed resistances to almost all the antibiotics except levofloxaci n, ciprofloxacin, imipenem while the control showed resistance to thr ee. The LAB, L. fermentum inhibited five (83.3%) of the pathogens with zone diameter of 12 - 17 mm, followed by W . confusa inhibiting three (50%) with 15 - 17 mm. Lactobacillus johnsonii on the other hand, inhibited a pathogen and the control with zones of 13 mm and 14 mm respectively. In conclusion, the extracted metabolites of LAB inhibited the growth of multi-drug resistant clinical isolates of uropathogenic S . saprophyticus and may therefore be potent alternatives to antibiotics.
机译:尿羟疗法葡萄球菌 Saprophyticus是分别报告的,抗常旧用于治疗泌尿道感染(UTI)的药物耐药。它们表现出对多种药物的抵抗力的能力是威胁在utis管理中记录的成功的威胁,因为该病原体导致D.已经证明乳酸菌(实验室)表现出母细胞活性,但研究其对多层抗性的前景 S. 嗜酸性脂肪菌很少。因此,该研究调查了实验室的Acti Vities免受多种毒性抗药性。 Saprophyticus恢复症状女性的尿液样本。三种不同的实验室(乳杆菌 发酵BTA 62,乳酸杆菌 johnsonii bta 86和 Weis Sella 根据其抗微生物活性历史,选择先前分离和鉴定的Confusa BTA 40)。它们在拮抗的测定中使用它们的抗逆转录测定抗六(6)亩LTI-药物抵抗力试验病原体来回症状,非孕妇的尿液样本,在Lagos,尼日利亚和对照中参加诊所(。< i> Saprophyticus潜伏Bovis菌株DSM 18669)按照标准程序。病原体显示出除左氟醚N,环氟氯酰基,伊皮脂,InfipeNem的几乎所有抗生素的电阻,而对照显示对Thr EE的抗性。实验室, L. 发酵蛋虫抑制了五个(83.3%)的菌,区域直径为12-17毫米,然后是 w。 comumsa抑制了15-17毫米的三(50%)。 乳酸杆菌 johnsonii在另一方面,抑制了病原体,分别用13mm和14mm的区域进行控制。总之,实验室提取的代谢产物抑制了尿胆酸尿酚硫致病菌的多药物抗性临床分离株的生长。 saprophyticus,因此可能是抗生素的有效替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号